Literature DB >> 27510751

Prevalence and Predictors of Gastroesophageal Reflux Complications in Community Subjects.

Nicholas R Crews1, Michele L Johnson2, Cathy D Schleck3, Felicity T Enders3, Louis-Michel Wongkeesong2, Kenneth K Wang2, David A Katzka2, Prasad G Iyer4.   

Abstract

BACKGROUND: Predictors of erosive esophagitis (EE) and Barrett's esophagus (BE) and the influence of number of risk factors in the community are not well defined.
METHODS: Rates of BE and EE among community residents identified in a randomized screening trial were defined. The risk of EE and BE associated with single and multiple risk factors (gender, age, GERD, Caucasian ethnicity, ever tobacco use, excess alcohol use, family history of BE or EAC, and central obesity) was analyzed.
RESULTS: Sixty-eight (33 %) of 205 subjects had EE and/or BE. BE prevalence was 7.8 % with dysplasia present in 1.5 %. Rates were comparable between subjects with and without GERD. Male sex and central obesity were independent risk factors. The odds of EE or BE were 3.7 times higher in subjects with three or four risk factors and 5.7 times higher in subjects with five or more risk factors compared with those with two or less factors.
CONCLUSIONS: EE and BE are prevalent in the community regardless of the presence of GERD. Risk appeared to be additive, increasing substantially with three or more risk factors.

Entities:  

Keywords:  Barrett’s esophagus; Esophageal adenocarcinoma; Obesity; Predictors; Randomized trial; Screening; Transnasal endoscopy

Mesh:

Year:  2016        PMID: 27510751      PMCID: PMC5069175          DOI: 10.1007/s10620-016-4266-3

Source DB:  PubMed          Journal:  Dig Dis Sci        ISSN: 0163-2116            Impact factor:   3.199


  33 in total

Review 1.  Central adiposity is associated with increased risk of esophageal inflammation, metaplasia, and adenocarcinoma: a systematic review and meta-analysis.

Authors:  Siddharth Singh; Anamay N Sharma; Mohammad Hassan Murad; Navtej S Buttar; Hashem B El-Serag; David A Katzka; Prasad G Iyer
Journal:  Clin Gastroenterol Hepatol       Date:  2013-05-22       Impact factor: 11.382

Review 2.  Body mass index and gastroesophageal reflux disease: a systematic review and meta-analysis.

Authors:  Douglas A Corley; Ai Kubo
Journal:  Am J Gastroenterol       Date:  2006-09-04       Impact factor: 10.864

3.  The development and validation of an endoscopic grading system for Barrett's esophagus: the Prague C & M criteria.

Authors:  Prateek Sharma; John Dent; David Armstrong; Jacques J G H M Bergman; Liebwin Gossner; Yoshio Hoshihara; Janusz A Jankowski; Ola Junghard; Lars Lundell; Guido N J Tytgat; Michael Vieth
Journal:  Gastroenterology       Date:  2006-08-16       Impact factor: 22.682

4.  A multibiomarker risk score helps predict risk for Barrett's esophagus.

Authors:  Aaron P Thrift; Jose M Garcia; Hashem B El-Serag
Journal:  Clin Gastroenterol Hepatol       Date:  2013-12-19       Impact factor: 11.382

5.  Health benefits and cost effectiveness of endoscopic and nonendoscopic cytosponge screening for Barrett's esophagus.

Authors:  Tatiana Benaglia; Linda D Sharples; Rebecca C Fitzgerald; Georgios Lyratzopoulos
Journal:  Gastroenterology       Date:  2012-10-03       Impact factor: 22.682

6.  Association of Barrett's esophagus with type II Diabetes Mellitus: results from a large population-based case-control study.

Authors:  Prasad G Iyer; Bijan J Borah; Herbert C Heien; Ananya Das; Gregory S Cooper; Amitabh Chak
Journal:  Clin Gastroenterol Hepatol       Date:  2013-04-13       Impact factor: 11.382

7.  Screening for Barrett's esophagus in colonoscopy patients with and without heartburn.

Authors:  Douglas K Rex; Oscar W Cummings; Michael Shaw; Mark D Cumings; Roy K H Wong; Raj S Vasudeva; Donal Dunne; Emad Y Rahmani; Debra J Helper
Journal:  Gastroenterology       Date:  2003-12       Impact factor: 22.682

8.  Successful elimination of reflux symptoms does not insure adequate control of acid reflux in patients with Barrett's esophagus.

Authors:  D A Katzka; D O Castell
Journal:  Am J Gastroenterol       Date:  1994-07       Impact factor: 10.864

9.  Combined effects of obesity, acid reflux and smoking on the risk of adenocarcinomas of the oesophagus.

Authors:  D C Whiteman; S Sadeghi; N Pandeya; B M Smithers; D C Gotley; C J Bain; P M Webb; A C Green
Journal:  Gut       Date:  2007-10-11       Impact factor: 23.059

10.  British Society of Gastroenterology guidelines on the diagnosis and management of Barrett's oesophagus.

Authors:  Rebecca C Fitzgerald; Massimiliano di Pietro; Krish Ragunath; Yeng Ang; Jin-Yong Kang; Peter Watson; Nigel Trudgill; Praful Patel; Philip V Kaye; Scott Sanders; Maria O'Donovan; Elizabeth Bird-Lieberman; Pradeep Bhandari; Janusz A Jankowski; Stephen Attwood; Simon L Parsons; Duncan Loft; Jesper Lagergren; Paul Moayyedi; Georgios Lyratzopoulos; John de Caestecker
Journal:  Gut       Date:  2013-10-28       Impact factor: 23.059

View more
  8 in total

1.  The global prevalence of Barrett's esophagus: A systematic review of the published literature.

Authors:  Inês Marques de Sá; Pedro Marcos; Prateek Sharma; Mário Dinis-Ribeiro
Journal:  United European Gastroenterol J       Date:  2020-07-06       Impact factor: 4.623

Review 2.  Can We Use Diet to Effectively Treat Esophageal Disease? A Review of the Current Literature.

Authors:  Carolyn Newberry; Kristle Lynch
Journal:  Curr Gastroenterol Rep       Date:  2017-08

Review 3.  Recent Advances in Non-invasive Esophageal Tissue Sampling.

Authors:  David A Katzka
Journal:  Curr Gastroenterol Rep       Date:  2017-03

Review 4.  Endoscopic Screening for Barrett's Esophagus and Esophageal Adenocarcinoma: Rationale, Candidates, and Challenges.

Authors:  Amrit K Kamboj; David A Katzka; Prasad G Iyer
Journal:  Gastrointest Endosc Clin N Am       Date:  2020-10-21

Review 5.  Recent Advances in Screening for Barrett's Esophagus.

Authors:  Sarmed S Sami; Prasad G Iyer
Journal:  Curr Treat Options Gastroenterol       Date:  2018-03

6.  Identification of key pathways and genes in Barrett's esophagus using integrated bioinformatics methods.

Authors:  Cong Zhang; Yujie Shen; Jiazheng Wang; Mingxia Zhou; Yingwei Chen
Journal:  Mol Med Rep       Date:  2017-12-12       Impact factor: 2.952

7.  Dietary habits and obesity indices in patients with gastro-esophageal reflux disease: a comparative cross-sectional study.

Authors:  Omid Eslami; Mansour Shahraki; Ali Bahari; Touran Shahraki
Journal:  BMC Gastroenterol       Date:  2017-11-28       Impact factor: 3.067

8.  Study on the relationship of depression, anxiety, lifestyle and eating habits with the severity of reflux esophagitis.

Authors:  Rongxin Wang; Jing Wang; Shuiqing Hu
Journal:  BMC Gastroenterol       Date:  2021-03-20       Impact factor: 3.067

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.